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Article 1 
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Abstract: The implementation of Molecularly Imprinted Polymers (MIPs) into sensing systems has 14 
been demonstrated abundantly over the past decades. In this article, a novel application for a MIP-15 
based thermal sensing platform is introduced by using the sensor to characterize the drug release 16 
kinetics of a nano-sized silver-organic framework. This so-called Ag-nanosponge was loaded with 17 
acetylsalicylic acid (aspirin) which was used as a model drug compound in this study. The drug 18 
elution properties were studied by placing the nanosponge in phosphate buffered saline solution 19 
for two days and measuring the drug concentration at regular time intervals. To this extent, an 20 
acrylamide-based MIP was synthesized that was able to detect aspirin in a specific and selective 21 
manner. Rebinding of the template to the MIP was analyzed using a thermal sensor platform. The 22 
results illustrate that addition of aspirin into the sensing chamber leads to a concentration-23 
dependent increase in the phase shift of a thermal wave that propagates through the MIP-coated 24 
sensor chip. After constructing a dose-response curve, this system was used to study the drug 25 
release kinetics of the nanosponge, clearly demonstrating that the metalorganic framework releases 26 
the drug steadily over the course of the first hour after which the concentration reaches a plateau. 27 
These findings were further confirmed by UV-VIS spectroscopy, illustrating a similar time-28 
dependent release in the same concentration range, which demonstrates that the MIP-based 29 
platform can be used as a low-cost, straightforward tool to assess the efficacy of drug delivery 30 
systems in a lab environment.  31 
Keywords: Molecularly imprinted polymers, thermal detection, nanosponge, drug delivery. 32 
 33 
1. Introduction 34 
Molecular imprinting technology originally focused on the development of imprinted particles that 35 
could be packed into columns for affinity separation, exploiting the affinity and selectivity to extract 36 
a molecule of interest from complex matrices [1-3]. The concept was soon extended by using 37 
molecularly imprinted polymers (MIPs) as antibody or enzyme mimics [4, 5]. One of the most 38 
interesting applications for MIPs is their incorporation into biomimetic sensing devices as they mimic 39 
the affinity of a natural receptor for its target, but are superior in terms of their chemical, thermal and 40 
long term stability [6-8] and can be made through a straightforward and relatively low-cost synthesis 41 
process [9]. Although MIPs have been combined with optical [10, 11], electrochemical [12-15], 42 
microgravimetric [16, 17], and thermal transducers [18-22] in devices with great potential for e.g. 43 
diagnostic applications, the translation of these lab-based devices into commercially available sensors 44 
is still challenging due to difficulties with reproducibility, integrated sampling and automated signal 45 
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processing [23]. Therefore, this paper illustrates a new potential application for MIP-based sensing 46 
systems, i.e. the study of the elution kinetics of drug delivery systems. 47 
 48 
Nanosponges are virus-sized particles that can be used as smart drug delivery systems due to their 49 
biodegradable polymer framework [24]. Cross-linking of the polymer leads to the formation of 50 
spherical nanoparticles with a large amount of binding cavities that could be used to store drugs for 51 
steady release [25]. The solubility of drugs that poorly dissolve in water can be regulated by carefully 52 
tuning the composition of the polymer and balancing the ratio of lipophilic and hydrophilic segments 53 
[26]. Over the past ten years, nano-sized metal-organic frameworks have emerged as an interesting 54 
class of nanosponges due to their non-toxic nature and unusually large loadings of a wide variety of 55 
drugs [27]. In addition, they can be made without using organic solvents and have shown to release 56 
drugs in a gradual and sustaining manner which can be tuned by modifying the organic linkers 57 
within their binding cavities [28]. Due to their size they can reach tightly controlled areas of the body, 58 
allowing to selectively target a desired area. 59 
 60 
Drug elution kinetics from smart drug delivery systems are traditionally studied by measuring the 61 
concentration of the drug in the medium surrounding the drug carrier. The drug concentration is 62 
usually determined by classic laboratory devices/techniques including radioactive assays [28], 63 
fluorescent resonance energy transfer [29], liquid chromatography [30] and UV-visible spectroscopy 64 
[31]. Although these methods are usually very sensitive and allow for a very accurate determination 65 
of the drug concentration and hence the elution profile, most of them require expensive readout 66 
devices, involve target labeling, or suffer from interference, limiting their performance in complex 67 
media. Therefore selective, label-free techniques have been studied based on e.g. electrochemical [32] 68 
and microgravimetrical [33] readout methods. These platforms allow for a straightforward and 69 
relatively fast analysis of the eluted medium but still require ultrasensitive, expensive readout 70 
technology, conductive electrodes and involved data processing and interpretation. 71 
 72 
Therefore, we introduce an elegant MIP-based platform for the study of drug elution from a metal-73 
organic framework in this article. Silver metalorganic frameworks were synthesized crosslinking 74 
AgNO3 with ethylenediamine in a sodium hydroxide solution leading to a sponge-like structure 75 
containing a wide distribution of nanocavities. These nanosponges were loaded with the model drug, 76 
acetylsalicylic acid (aspirin), one of the drugs most abundantly used for the treatment of pain, fever, 77 
or inflammation that has also demonstrated to possess antithrombotic effects which positively affects 78 
patients at risk for heart failure [34]. The drug elution under physiological conditions was studied in 79 
the lab by applying aspirin-imprinted MIPs to aluminum electrodes and studying the propagation of 80 
a thermal wave through the chip in function of an increasing concentration of acetylsalicylic acid, a 81 
technique that was used successfully for the detection of dopamine in banana juice in previous work 82 
[21]. Next, the constructed dose-response curve from this experiment was used to determine the 83 
aspirin concentration in PBS solution containing drug eluted from the nanosponge. The results 84 
demonstrated that the nanosponge releases the drugs in a burst-like manner, releasing the drug in a 85 
constant fashion during the first hour, after which the concentration in the media surrounding the 86 
sponge remains stable. These results were validated using UV-Visible spectroscopy, which shows a 87 
similar behavior and a similar concentration range, illustrating the potential of the platform for drug 88 
elution studies.  89 
2. Materials and Methods  90 
2.1. Chemicals 91 
Acrylamide (AA), azobisisobutyronitrile (AIBN), polyvinylchloride (PVC) and silver nitrate 92 
(AgNO3) were obtained from Sigma-Aldrich. Methanol (absolute) and acetonitrile were bought at 93 
Biosolve. Acetone (pure), sodium hydroxide, sulfuric acid, ethanol, salicylic acid and phosphate 94 
buffered saline (PBS) tablets were acquired from VWR chemicals. Ethylenediamine (EDA), hydrazine 95 
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hydrate and ethylene glycol dimethacrylate (EGDM) were procured from Merck Schuchardt OHG. 96 
Polydimethysiloxane (PDMS) stamps were made with the Sylgard 184 elastomer kit from Mavom 97 
NV. Aluminum chips were purchased at Brico NV and cut to the desired dimensions. 98 
2.2. Synthesis of the metalorganic framework (silver nanosponge) 99 
Nanosponges were synthesized by mixing aqueous AgNO3 (5 mL, 0.4M, 2 mmol) with aqueous 100 
NaOH (150 mL, 15 M, 2.25 mol). Crosslinking was initiated by the addition of aqueous EDA (1.5 mL, 101 
99% w/v, 0.25 mmol) and aqueous hydrazine hydrate (0.2 mL, 80% w/v, 5.0 mmol) to the solution. 102 
The mixture was then purged with N2 and refluxed at 80 °C for 90 minutes. After cooling the reaction 103 
flask to room temperature, silver nanosponges were isolated by vacuum filtration and air dried 104 
before being freeze dried for 6 hours. 105 
2.3. Molecular imprinting procedure 106 
Pre-polymerization mixtures composed of aspirin (0.090 g, 0.5 mmol), 3 mmol AA (0.213 g) and 15 107 
mmol EGDM were dissolved in 5 mL acetonitrile. Polymerization was initiated by adding 0.15 mmol 108 
AIBN (0.025 g) to the pre-polymerization mixture. After sonication, the mixture was deoxygenated 109 
by purging it for 5 minutes with N2 and heated to 60 °C during 24 hours while shielding the mixture 110 
from light to prevent the template from degrading. The resulting monolith was mechanically ground 111 
using a Fritsch Planetary Micro Mill Pulverisette 7 premium line (700 rpm, 5 minutes, 10 mm balls) 112 
and sieved using a using a Fritsch Analysette 3 for 4 hours with a 20 µm mesh. The resulting powder 113 
was extracted during 96 hours at 105 °C, using a Soxhlet apparatus filled with with a mixture of 114 
methanol and ethanoic acid (7:3 v/v). Finally, the MIP particles were dried for three hours in an oven 115 
at 50 °C. Non-imprinted polymers (NIPs), serving as a reference, were synthesized in the same 116 
manner without the presence of a template.  117 
2.4. Chip preparation 118 
Polished aluminium plates were cut to obtain chips with the desired dimensions (10 × 10 mm2). To 119 
immobilize MIP particles onto the surface of the measurement chip, a 100 nm PVC adhesive layer 120 
(0.35 wt% PVC dissolved in tetrahydrofuran) was applied onto the chip by spin coating at 3000 rpm 121 
for 60 seconds with an acceleration of 1100 rpm/s. MIP and NIP particles were stamped into this 122 
layer using a PDMS substrate that was covered with a monolayer of polymer particles. The PVC 123 
layer was heated for 2 hours at a temperature of 100 °C way above its glass transition temperature 124 
(80 °C) allowing beads to sink into the polymer layer. The samples were cooled down prior to 125 
thermal measurements and any unbound particles were washed off with distilled water. 126 
2.5. Selectivity test and dose-response curve  127 
The thermal detection platform is described thoroughly in previous work [18-22]. Functionalized 128 
chips (MIP or NIP) were pressed mechanically with their backside onto a copper block serving as a 129 
heat provider. The temperature of the copper underneath the sample, T1, was monitored by a K-type 130 
thermocouple (TC Direct). This information was fed into a temperature control unit that stringently 131 
controls T1 by modifying the voltage over the power resistor (Farnell) that heats the copper, using  a 132 
software-based (Labview, National Instruments) proportional-integral-derivative (PID) controller 133 
(P= 10, I= 8, D= 0). The functionalized side of the chip faced a polyether ether ketone (PEEK) flow cell 134 
which was sealed with an O-ring to avoid leakage, defining a contact area of 28 mm2 and an inner 135 
volume of 110 µL. The flow cell is connected to a tubing system, allowing the administration of 136 
liquids in a controlled and automated fashion by means of a syringe pump. The temperature of the 137 
liquid inside the flow cell, T2, is measured by a second thermocouple, placed 1 mm above the chip. 138 
For each rebinding measurement the signal was stabilized in PBS at pH 7.4 which was used as to 139 
mimic physiological conditions.  140 
2.6. Loading of nanosponges with aspirin  141 
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Aspirin was absorbed into the nanosponges by solvent evaporation. To this extent 1.85 mmol (0.100 142 
g) of the nanosponge was incubated with a 1.85 mmol aspirin in 6.2 mL of ethanol. The mixture was 143 
shaken for 48 hours at 750 rpm. The solvent was removed under vacuum (30 °C, 300 mbar, 90 rpm) 144 
and dried at 65 °C for 3 hours. 145 
2.7. Drug elution analysis 146 
Loaded nanosponges (0.1 g) were incubated in 300 mL PBS (pH 7.4 at 37 °C) while gently stirringat 147 
100 rpm to mimic physiological conditions. Over the course of two days, 3 mL samples of the PBS 148 
were taken at regular time intervals and the aspirin concentration was analyzed by both TWTA and 149 
UV-visible spectroscopy to create an elution profile. 150 
3. Results and Discussion 151 
3.1. Surface characterization of Ag nanosponges 152 
Upon synthesis the Ag nanosponges were analyzed using scanning electron microscopy (SEM). This 153 
analysis reveals that the metalorganic framework indeeds has a nanosponge structure containing a 154 
large set of nano-sized cavities, providing a large a surface area that can be loaded with drug 155 
molecules.  156 
 157 
Figure 1. Surface analysis of an Ag-nanosponge using a scanning electron microscope at magnification 2500x.   158 
3.2. Quantification of aspirin in PBS 159 
To assess whether it was possible to accurately determine the concentration of drug eluted from the 160 
nanosponge, a dose-response curve was constructed by exposing a MIP-coated chip to an increasing 161 
concentration of aspirin in PBS. The thermal analysis clearly indicates that exposing the MIP to 162 
aspirin in increasing concentrations results in a decrease of the liquid temperature inside the flow 163 
chamber (Figure 2a) and a increase in the phase shift observed in the transmitted wave (Figure 2b). 164 
The results in figure 2b were used to construct a thermal bode plot which shows a the phase shift for 165 
each transmitted frequency in function of the cummulative concentration of aspirin present in the 166 
flow cell (Figure 3c). Although the phase shift at every concentration is most pronounced at the 167 
highest input frequency, the resolution appears to be optimal at 0.03 Hz. These findings are in line 168 
with previously obtained results with dopamine MIPs in a similar setup [21]. The time-dependent 169 
TWTA data at 0.03 Hz are used to construct a dose-response curve (figure 3d), which will be used to 170 
assess the concentration of aspirin that has eluted from the Ag-nanosponge.   171 
 172 
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 174 
Figure 2. Aspirin rebinding analysis. The time-dependent temperature data (a) and thermal wave transport 175 
analysis spectrum (b) are shown in response to adding an increasing concentration of aspirin. The phase shift at 176 
an optimal resolution at frequency 0,03 Hz (c) and a dose-response curve (d) are constructed from these data 177 
and are plotted in function of the cummulative concetration present in the flow chamber. 178 
3.3. Selectivity test 179 
In order to assess whether the aspirin recognition was selective and specific, the experiment 180 
summarized in the previous section was repeated for a NIP-coated electrode. In addition, both MIP 181 
and NIP were exposed to an increasing concentration of acetaminophen (paracetamol). The resulting 182 
dose-response curves and the corresponding fits are shown in Figure 3.  183 
 184 
Figure 3. MIP selectivity test. The data show that exposing both the aspirin MIP and the NIP do not respond to 185 
an increasing concentration of the analogue molecule. However, the imprinting factor is limited as the difference 186 
between MIP and NIP is small. 187 
The results in figure 3, illustrate that although the MIP is suprisingly selective in discriminating 188 
between paracetamol and aspirin, the imprinting factor is small. This in line with previous findings 189 
with similar AA-based MIPs and can be explained by the fact that at a neutral pH, not all binding 190 
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sites and functional groups on the target will be protonated (pKa of aspirin is 3.49) [35]. The fact that 191 
paracetamol only slightly increases the phase shift is suprising as the non-specific binding to the MIP 192 
was expected to be similar. Although previous work has indicated that the MIP would be more 193 
specific and therefore, selective at acidic pHs, the authors decided to continue measuring at a pH of 194 
7.4 to simulate drug elution. The results in Figure 2 indicate that the dose-response curve is highly 195 
usable and as the release pattern will be studied in PBS no interference from other molecules is to be 196 
expected. However, if the concept would be extend to complex matrices in the future the MIP 197 
synthesis route should be revised. 198 
3.4. Thermal analysis of drug elution 199 
The elution of aspirin from the nanosponges was studied by incubating them in PBS and retrieving 200 
a sample from the surrounding medium after 1, 10, 30, 120 and 360 minutes and after 48 hours. The 201 
elutions were diluted 5000 times with PBS to fit the linear range of the sensor. MIP-coated electrodes 202 
were exposed to these diluted elutions and their response was summarized in a temperature bode 203 
plot (figure 4a). The resulting phase shifts at 0.03 Hz were used to construct an elution profile that 204 
was compared to the previously obtained dose response curve (figure 4b) to determine the aspirin 205 
concentration in each of the eluted samples.  206 
 207 
Figure 4. Drug elution analysis. The drug elution was studied using TWTA and the resulting Bode plot shows a 208 
concentration-dependent phase shift indicating that the concentration of aspirin gradually increases with time 209 
(a). The dose-response curve was used to determine the concentration in the eluted solutions (b).  210 
The results obtained in Figure 4 were corrected for the dilution factor to create an elution profile that 211 
validated using a gold standard reference technique, i.e. UV-Visible spectroscopy. The elution 212 
profiles of both techniques demonstrate a similar behavior (Figure 5a): a sharp increase within the 213 
first two hours after which a stable plateau is reached that does not significantly change over the next 214 
two days. This indicates that the nanosponge releases the drugs in a relatively quick burst which is 215 
suitable for some applications requiring immediate effect. However, to actually achieve sustained, 216 
prolonged delivery of drugs the nanosponge should be functionalized with molecules that bind the 217 
drug and actually release it slowly over time.  218 
When analyzing the elution profile obtained by UV-Visible spectroscopy, a small decrease in the 219 
concentration of aspirin can be observed over the course of two days. This can be explained by the 220 
fact that some of the acetylsalicylic acid will be converted into salicylic acid in PBS. This is confirmed 221 
by analyzing UV absorbance at 295.5 nm, which shows that salicylic acid is indeed present in the 222 
elution and its concentration will increase slightly over the course of two days (Figure 5b). The fact 223 
that this is not shown in the TWTA data is due to the fact that both compounds will bind to the MIP 224 
in a similar manner [35]. 225 
 226 
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 227 
Figure 5. Validation of TWTA data by UV-Visible spectroscopy. The drug elution profile derived from the TWTA 228 
data in figure 4 were compared to the drug elution profile obtained with UV-Vis and both show a initial burst 229 
of aspirin release in the first two hours in the milimolar regime (a). The decrease in aspirin concentration for the 230 
UV-vis data shown in figure 5a can be explained by conversion of aspirin into salicylic acid which is confirmed 231 
by analyzing absorbance at 295.5 nm. 232 
4. Conclusions 233 
The data shown in this article illustrate the potential use of a MIP-based thermal detection platform, 234 
which has previously been used for diagnostic purposes, for analyzing the drug release kinetics of 235 
drug delivery matrices. A proof-of-principle was demonstrated by validating the results obtained 236 
with the biomimetic sensor using UV-Visible spectroscopy, demonstrating a similar profile in the 237 
same concentration range. The metalorganic framework synthesized in this work appears to release 238 
the model drug, aspirin, within the first two hours. Future research should be aimed at 239 
functionalizing the framework to get to a more gradual release of the drug. In addition, loading and 240 
elution of other, potentially more relevant drugs should also be studied. As the MIP platform is 241 
generic, it can be used to study a wide variety of targets in a wide variety of matrices, by changing 242 
the MIP receptors or optimizing their selectivity or performance in more challenging media and 243 
chemical conditions (pH, temperature,…). Additionally, the platform has been recently tested for 244 
detecting molecules directly on a thermocouple wire [36], this opens up perspectives in terms of 245 
analyzing drug release in vivo using the proposed platform.   246 
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